Alzheimer's Disease

Study may provide critical insights for personalized medicine related to late-onset Alzheimer’s disease

Identifying genetic risk factors for Alzheimer's disease to improve our understanding and treatment of it

Test is up to 93 percent accurate at identifying people at risk of Alzheimer's dementia

The team identified hundreds of traits, including male- or female-biased diseases such as lupus, that may be influenced

Researchers say testing will help identify early cognitive decline

Protein deposits in retina and brain appear to parallel possible neurodegeneration

Outreach Pro aimed at increasing underrepresented population participation

Neurodegeneration can be identified using a combination of biomarkers in cerebrospinal fluid of living patients

Methodology for analyzing high-risk pedigrees can be used to prioritize rare genetic variants

International clinical trial yields mixed results with unclear cognitive effects but promising biomarker results